Richard Elliott

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer

María Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar et al. · Cancer Research · 2016 · 742 citations · Full text

Pi3k Inhibitors, Breast Oncology, Estrogen Receptor +19

BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency

Yuqiao Shen, Farah Rehman, Ying Feng et al. · Clinical Cancer Research · 2013 · 477 citations · Full text

A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

Nicholas C. Turner, Christopher J. Lord, Elizabeth Iorns et al. · The EMBO Journal · 2008 · 323 citations · Full text

Parp Inhibitor, Natural Sciences, Genetics +8

Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer

Elizabeth Iorns, Nicholas C. Turner, Richard Elliott et al. · Cancer Cell · 2008 · 228 citations · Full text

Breast Oncology, Oncology, Medicine +10

Inactivation of Effector Caspases through Nondegradative Polyubiquitylation

Mark Ditzel, Meike Broemer, Tencho Tenev et al. · Molecular Cell · 2008 · 130 citations · Full text

Functional Modification, Signal Transduction, Biomedical Research +4